The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
Open accessAbstract
BACKGROUND: Clinical trials have confirmed that surfactant therapy is effective in improving the immediate need for respiratory support and the clinical outcome of premature newborns. Trials have studied a wide variety of surfactant preparations used either to prevent (prophylactic or delivery room administration) or treat (selective or rescue administration) respiratory distress syndrome (RDS). Using either treatment strategy, significant reductions in the incidence of pneumothorax, as well as significant improvement in survival, have been noted. It is unclear whether there are any advantages to treating infants with respiratory insufficiency earlier in the course of RDS. OBJECTIVES: To compare the effects of early versus delayed selective surfactant therapy for newborns intubated for respiratory distress within the first two hours of life. Planned subgroup analyses included separate comparisons for studies utilizing natural surfactant extract and synthetic surfactant. SEARCH METHODS: We searched the Oxford Database of Perinatal Trials, MEDLINE (MeSH terms: pulmonary surfactant; text word: early; limits: age, newborn: publication type, clinical trial), PubMed, abstracts, conference and symposia proceedings, expert informants, and journal handsearching in the English language. For the updated search in April 2012 we searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, 2012, Issue 1) and PubMed (January 1997 to April 2012). SELECTION CRITERIA: Randomized and quasi-randomized controlled clinical trials comparing early selective surfactant administration (surfactant administration via the endotracheal tube in infants intubated for respiratory distress, not specifically for surfactant dosage) within the first two hours of life versus delayed selective surfactant administration to infants with established RDS were considered for review. DATA COLLECTION AND ANALYSIS: Data regarding clinical outcomes were excerpted from the reports of the clinical trials by the review authors. Subgroup analyses were performed based on type of surfactant preparation, gestational age, and exposure to prenatal steroids. Data analysis was performed in accordance with the standards of the Cochrane Neonatal Review Group. MAIN RESULTS: Six randomized controlled trials met selection criteria. Two of the trials utilized synthetic surfactant (Exosurf Neonatal) and four utilized animal-derived surfactant preparations.The meta-analyses demonstrate significant reductions in the risk of neonatal mortality (typical risk ratio (RR) 0.84; 95% confidence interval (CI) 0.74 to 0.95; typical risk difference (RD) -0.04; 95% CI -0.06 to -0.01; 6 studies; 3577 infants), chronic lung disease (typical RR 0.69; 95% CI 0.55 to 0.86; typical RD -0.04; 95% CI -0.06 to -0.01; 3 studies; 3041 infants), and chronic lung disease or death at 36 weeks (typical RR 0.83; 95% CI 0.75 to 0.91; typical RD -0.06; 95% CI -0.09 to -0.03; 3 studies; 3050 infants) associated with early treatment of intubated infants with RDS.Intubated infants randomized to early selective surfactant administration also demonstrated a decreased risk of acute lung injury including a decreased risk of pneumothorax (typical RR 0.69; 95% CI 0.59 to 0.82; typical RD -0.05; 95% CI -0.08 to -0.03; 5 studies; 3545 infants), pulmonary interstitial emphysema (typical RR 0.60; 95% CI 0.41 to 0.89; typical RD -0.06; 95% CI -0.10 to -0.02; 3 studies; 780 infants), and overall air leak syndromes (typical RR 0.61; 95% CI 0.48 to 0.78; typical RD -0.18; 95% CI -0.26 to -0.09; 2 studies; 463 infants).A trend toward risk reduction for bronchopulmonary dysplasia (BPD) or death at 28 days was also evident (typical RR 0.94; 95% CI 0.88 to 1.00; typical RD -0.04; 95% CI -0.07 to -0.00; 3 studies; 3039 infants). No differences in other complications of RDS or prematurity were noted.Only two studies reported on infants under 30 weeks' gestation. Decreased risk of neonatal mortality and chronic lung disease or death at 36 weeks' postmenstrual age was noted. AUTHORS' CONCLUSIONS: Early selective surfactant administration given to infants with RDS requiring assisted ventilation leads to a decreased risk of acute pulmonary injury (decreased risk of pneumothorax and pulmonary interstitial emphysema) and a decreased risk of neonatal mortality and chronic lung disease compared to delaying treatment of such infants until they develop worsening RDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nasal CPAP or Intubation at Birth for Very Preterm Infants
Morley, C. J., Davis, P. G., Doyle, L. W., Brion, L. P., Hascoet, J.-M., & Carlin, J. B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072788 · Cited by 1,354
Early CPAP versus Surfactant in Extremely Preterm Infants
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911783 · Cited by 1,043
Rojas-Reyes, M. X., Morley, C. J., & Soll, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000510.pub2 · Cited by 652
Self-citationStevens, T. P., Blennow, M., Myers, E. H., & Soll, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003063.pub3 · Cited by 597
Self-citationImmunomodulatory functions of surfactant
Wright, J. R. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.931 · Cited by 576
Effective Care of the Newborn Infant
Speidel, B. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.11.1415-a · Cited by 550
Randomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm Neonates
Dunn, M. S., Kaempf, J., de Klerk, A., de Klerk, R., Reilly, M., Howard, D., Ferrelli, K., O'Conor, J., Soll, R. F., & for the Vermont Oxford Network DRM Study Group (2011) · Pediatrics · doi:10.1542/peds.2010-3848 · Cited by 515
Self-citationGöpel, W., Kribs, A., Ziegler, A., Laux, R., Hoehn, T., Wieg, C., Siegel, J., Avenarius, S., von der Wense, A., Vochem, M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60986-0 · Cited by 466
Randomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm Neonates
Martin, R. J. (2012) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/j.ynpm.2012.05.007 · Cited by 352
Animal derived surfactant extract for treatment of respiratory distress syndrome
Seger, N., & Soll, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007836 · Cited by 260
Self-citation
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
Brok, J., Thorlund, K., Wetterslev, J., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn188 · Cited by 917
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Stevens, T. P., Blennow, M., Myers, E. H., & Soll, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003063.pub3 · Cited by 597
Self-citationRandomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm Neonates
Dunn, M. S., Kaempf, J., de Klerk, A., de Klerk, R., Reilly, M., Howard, D., Ferrelli, K., O'Conor, J., Soll, R. F., & for the Vermont Oxford Network DRM Study Group (2011) · Pediatrics · doi:10.1542/peds.2010-3848 · Cited by 515
Self-citationBrat, R., Yousef, N., Klifa, R., Reynaud, S., Shankar Aguilera, S., & De Luca, D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.1797 · Cited by 472
Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress
Polin, R. A., Carlo, W. A., COMMITTEE ON FETUS AND NEWBORN, Papile, L.-A., Polin, R. A., Carlo, W., Tan, R., Kumar, P., Benitz, W., Eichenwald, E., et al. (2014) · Pediatrics · doi:10.1542/peds.2013-3443 · Cited by 413
Randomized Trial Comparing 3 Approaches to the Initial Respiratory Management of Preterm Neonates
Martin, R. J. (2012) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/j.ynpm.2012.05.007 · Cited by 352
Short- and Long-Term Outcomes for Extremely Preterm Infants
Patel, R. (2016) · American Journal of Perinatology · doi:10.1055/s-0035-1571202 · Cited by 341
Respiratory Support in Preterm Infants at Birth
COMMITTEE ON FETUS AND NEWBORN, Papile, L.-A., Baley, J. E., Benitz, W., Cummings, J., Eichenwald, E., Kumar, P., Tan, R. C., & Wang, K. S. (2014) · Pediatrics · doi:10.1542/peds.2013-3442 · Cited by 330
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Engle, W. A., & and the Committee on Fetus and Newborn (2008) · Pediatrics · doi:10.1542/peds.2007-3283 · Cited by 308
Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions
the GAPPS Review Group, Barros, F. C., Bhutta, Z. A., Batra, M., Hansen, T. N., Victora, C. G., & Rubens, C. E. (2010) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-10-s1-s3 · Cited by 300
Alveolar epithelial cells: Master regulators of lung homeostasis
Guillot, L., Nathan, N., Tabary, O., Thouvenin, G., Le Rouzic, P., Corvol, H., Amselem, S., & Clement, A. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.08.009 · Cited by 294
Respiratory Distress in the Newborn
Reuter, S., Moser, C., & Baack, M. L. (2014) · Pediatrics in Review · doi:10.1542/pir.35-10-417 · Cited by 285
Animal derived surfactant extract for treatment of respiratory distress syndrome
Seger, N., & Soll, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007836 · Cited by 260
Self-citationLung Ultrasound Score Predicts Surfactant Need in Extremely Preterm Neonates
De Martino, L., Yousef, N., Ben-Ammar, R., Raimondi, F., Shankar-Aguilera, S., & De Luca, D. (2018) · Pediatrics · doi:10.1542/peds.2018-0463 · Cited by 255
Interventions to improve neonatal health and later survival: an overview of systematic reviews
Lassi, Z. S., Middleton, P. F., Crowther, C., & Bhutta, Z. A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.023 · Cited by 130
Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
Piva, S., DiBlasi, R. M., Slee, A. E., Jobe, A. H., Roccaro, A. M., Filippini, M., Latronico, N., Bertoni, M., Marshall, J. C., & Portman, M. A. (2021) · Respiratory Research · doi:10.1186/s12931-020-01603-w · Cited by 70
Metadata
- Authors
- Bahadue, F. L., & Soll, R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-11-14
- Volume
- 2012
- Issue
- 11
- Pages
- CD001456-CD001456
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2119117831
- Cited by
- 556
- References
- 22
- FWCI
- 24.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.